09.11.2013

Germany's Boehringer Ingelheim, is looking to expand its animal health business and is set to make an offer for poultry vaccine and feed additives maker Lohmann. Boehringer Ingelheim, which is among the world's top 10 suppliers of animal health products, is expected to submit a bid for privately-held Lohmann Animal Health by the 11th November deadline. The offer is expected to value Lohmann, which is owned by PHW Group, at about 400 million euros ($535 million), or 16 times its expected operating earnings.

Private equity groups such as Permira will also hand in offers for the group.

Lohmann booked a 4.9 per cent increase in turnover in fiscal 2011-12, from EUR 243.80 million to EUR 255.70 million.